Neoadjuvant study of Chemotherapy versus EndocriNe Therapy in postmenopausal patients with primary breast cancer
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Letrozole (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms Neo-CENT
- 31 Aug 2018 Biomarkers information updated
- 30 Jan 2014 Accrual to date is 110% according to UKCRN database record.
- 09 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.